These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 26530011)

  • 1. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
    Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
    Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV microRNA-BHRF1-2-5p targets the 3'UTR of immune checkpoint ligands PD-L1 and PD-L2.
    Cristino AS; Nourse J; West RA; Sabdia MB; Law SC; Gunawardana J; Vari F; Mujaj S; Thillaiyampalam G; Snell C; Gough M; Keane C; Gandhi MK
    Blood; 2019 Dec; 134(25):2261-2270. PubMed ID: 31856276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
    Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Epstein-Barr Virus MicroRNA Blocks Interleukin-1 (IL-1) Signaling by Targeting IL-1 Receptor 1.
    Skinner CM; Ivanov NS; Barr SA; Chen Y; Skalsky RL
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1.
    Song Y; Li X; Zeng Z; Li Q; Gong Z; Liao Q; Li X; Chen P; Xiang B; Zhang W; Xiong F; Zhou Y; Zhou M; Ma J; Li Y; Chen X; Li G; Xiong W
    Oncotarget; 2016 Jun; 7(24):36783-36799. PubMed ID: 27167345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV-miR-BHRF1-1 Targets p53 Gene: Potential Role in Epstein-Barr Virus Associated Chronic Lymphocytic Leukemia.
    Xu DM; Kong YL; Wang L; Zhu HY; Wu JZ; Xia Y; Li Y; Qin SC; Fan L; Li JY; Liang JH; Xu W
    Cancer Res Treat; 2020 Apr; 52(2):492-504. PubMed ID: 31671936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases.
    Nicholls J; Kremmer E; Meseda CA; Mackett M; Hahn P; Gulley ML; Brink A; Swinnen LJ; Greenspan J; De Souza Y; Grässer F; Sham J; Ng MH; Arrand JR
    J Med Virol; 2001 Sep; 65(1):105-13. PubMed ID: 11505451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma.
    Imig J; Motsch N; Zhu JY; Barth S; Okoniewski M; Reineke T; Tinguely M; Faggioni A; Trivedi P; Meister G; Renner C; Grässer FA
    Nucleic Acids Res; 2011 Mar; 39(5):1880-93. PubMed ID: 21062812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr Virus miR-BHRF1-3 Targets the BZLF1 3'UTR and Regulates the Lytic Cycle.
    Fachko DN; Chen Y; Skalsky RL
    J Virol; 2022 Feb; 96(4):e0149521. PubMed ID: 34878852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of a viral microRNA is regulated by clustering to allow optimal B cell transformation.
    Haar J; Contrant M; Bernhardt K; Feederle R; Diederichs S; Pfeffer S; Delecluse HJ
    Nucleic Acids Res; 2016 Feb; 44(3):1326-41. PubMed ID: 26635399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas.
    Cao P; Zhang M; Wang L; Sai B; Tang J; Luo Z; Shuai C; Zhang L; Li Z; Wang Y; Li G; Xiang J
    BMC Cancer; 2018 Dec; 18(1):1293. PubMed ID: 30594162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAX1BP1 downregulation by EBV-miR-BART15-3p enhances chemosensitivity of gastric cancer cells to 5-FU.
    Choi H; Lee SK
    Arch Virol; 2017 Feb; 162(2):369-377. PubMed ID: 27757686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.
    Shinozaki-Ushiku A; Kunita A; Isogai M; Hibiya T; Ushiku T; Takada K; Fukayama M
    J Virol; 2015 May; 89(10):5581-91. PubMed ID: 25740983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr Virus (EBV)-BamHI-A Rightward Transcript (BART)-6 and Cellular MicroRNA-142 Synergistically Compromise Immune Defense of Host Cells in EBV-Positive Burkitt Lymphoma.
    Zhou L; Bu Y; Liang Y; Zhang F; Zhang H; Li S
    Med Sci Monit; 2016 Oct; 22():4114-4120. PubMed ID: 27796281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma.
    Zhang T; Ma J; Nie K; Yan J; Liu Y; Bacchi CE; Queiroga EM; Gualco G; Sample JT; Orazi A; Knowles DM; Tam W
    Blood Cancer J; 2014 Nov; 4(11):e261. PubMed ID: 25382611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Epstein-Barr virus miR-BHRF1-1 targets RNF4 during productive infection to promote the accumulation of SUMO conjugates and the release of infectious virus.
    Li J; Callegari S; Masucci MG
    PLoS Pathog; 2017 Apr; 13(4):e1006338. PubMed ID: 28414785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.
    Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL
    Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Epstein-Barr virus miR-BHRF1 microRNAs regulate viral gene expression in cis.
    Poling BC; Price AM; Luftig MA; Cullen BR
    Virology; 2017 Dec; 512():113-123. PubMed ID: 28950226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas.
    Sakamoto K; Sekizuka T; Uehara T; Hishima T; Mine S; Fukumoto H; Sato Y; Hasegawa H; Kuroda M; Katano H
    Cancer Med; 2017 Mar; 6(3):605-618. PubMed ID: 28181423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus.
    Feederle R; Linnstaedt SD; Bannert H; Lips H; Bencun M; Cullen BR; Delecluse HJ
    PLoS Pathog; 2011 Feb; 7(2):e1001294. PubMed ID: 21379335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.